Chronic warfarin anticoagulation is commonly used to prevent thromboembolism in patients with atrial fibrillation or venous thromboembolism, and in the management of patients with mechanical heart ...

Objective: To provide recommendations for optimized anticoagulant therapy in the inpatient setting and outline broad elements that need to be in place for effective management of anticoagulant therapy ...

Three or 6 months of anticoagulant therapy used to be the standard duration of treatment for almost all patients after a first episode of deep vein thrombosis or pulmonary embolism (collectively ...

A population-based cohort study found an association between bleeding events in Afib patients on oral anticoagulation and cancer diagnoses. In cases where cancer was diagnosed, it was more likely ...

Please provide your email address to receive an email when new articles are posted on . Anticoagulants are one of the most commonly prescribed medication classes, and the utilization of these agents ...

PATIENT PRESENTATION A woman in her late 50s with a history of hypertension and diabetes presented with severe, debilitating ...

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia that significantly elevates the risk of thromboembolic events, most notably ischaemic stroke. Anticoagulation therapy has long been a ...

Anticoagulants prevent the clotting of blood. They are administered orally or via injection. When a blood vessel is damaged, blood oozes out. However, bleeding stops amazingly within a few minutes ...

Background: Patients taking oral anticoagulant therapy balance the risks of hemorrhage and thromboembolism. We sought to determine the association between anticoagulation intensity and the risk of ...

Long-term warfarin anticoagulation is commonly used to prevent thromboembolism in patients with medical conditions such as atrial fibrillation and venous thromboembolism (VTE) (deep venous thrombosis ...